Judul: Analisis sistem antrian pada proses penyelesaian klaim di PT Taspen (Persero) Kantor Cabang Bogor
Abstrak: PT Taspen (Persero) Kantor Cabang (KC) Bogor merupakan badan usaha yang bergerak dalam bidang pelayanan publik. Ketidaksesuaikan antara petugas penyelesaian klaim dengan jumlah klaim menimbulkan fenomena antrian. Tujuan diadakannya penelitian ini 1) Menganalisis kinerja sistem antrian yang digunakan di PT Taspen (Persero) KC Bogor. 2) Menganalisis usulan model antrian yang dapat dikembangkan. 3) Menganalisis biaya antrian yang optimal dari model antrian yang dikembangkan. Pengumpulan data dilakukan melalui purposive sampling dengan mengukur kecepatan kedatangan peserta dan waktu pelayanan petugas dengan menggunakan stopwatch melalui proses pengamatan secara langsung. Pengambilan data kecepatan kedatangan peserta dilakukan setiap hari Senin-Jumat pada periode sibuk pukul 07.45 sampai dengan 11.00 WIB. Pengolahan dan analisis data dilakukan dengan bantuan program Waiting Line QM for Windows 2 dan Queuing System Simulation (QSS).
Keyword: 

Judul: Analisis Antrian Jasa Bank Pada Loket Teller Pt Bank X Kantor Cabang B
Abstrak: Salah satu dimensi pelayanan adalah menyangkut masalah antrian, yaitu menyangkut kecepatan pelayanan kepada nasabah. Masalah antrian berkaitan dengan keputusan manajemen untuk mempersiapkan kapasitas pelayanan dalam menghadapi permintaan konsumen yang bervariasi. Pada saat permintaan konsumen tinggi, kapasitas pelayanan menjadi terlalu sibuk sehingga menyebabkan antrian panjang. Sebaliknya pada saat permintaan sedikit maka fasilitas pelayanan menganggur sehingga tidak efisien. Manajemen perlu menyediakan fasilitas pelayanan yang optimal sehingga dapat melayani permintaan konsumen yang bervariasi dan dengan biaya yang sebanding...dst.
Keyword: operasional bank, masalah antrian, kecepatan pelayanan, peningkatan kinerja

Judul: Pengembangan Kultur sel dan Vaksin Inaktif untuk Pencegahan Infeksi Megalocytivirus pada Ikan Gurami (Osphronemus goramy).
Abstrak: Megalocytivirus of family Iridoviridae is a known pathogen that caused fatal systemic infection lead to massive death and significant economic losses of numerous fish species in marine, fresh water and ornamental fish industries. In Indonesia, since 2011 megalocytivirus had been found as main pathogen in some cases of giant gourami outbreak especially in West Java, Central Java and Bali. Rapid expansion and intensification in aquaculture has led to many cases of disease outbreaks. Mortality rates of fish due to viral infections is high and up to now there’s no effective treatment methods to overcome the problem. Prevention is a better choice than treatment although efforts to prevent and control diseases caused by viral infections are still difficult to do. The aim of this study was to develop a primary cell culture and an inactivated vaccine for megalocytivirus infection in giant gourami. The first stage of this study was conducted to identify and characterized megalocytivirus in cultured giant gourami. The virus was identified using universal and spesific primers for megalocytivirus and infectious spleen and kidney necrosis virus (ISKNV). Sequencing and BLAST analysis were used to develop phylogenetic tree. The result showed that phylogenetic analysis of major capsid protein (MCP) gene unveiled a new megalocytivirus strain, designated as giant gourami iridovirus (GGIV). GGIV formed cluster belonged to ISKNV and has 100% homology to ISKNV complete genome. Artificial infection by intraperitoneally injection with supernatant homogenate from spleen and kidney of naturally infected fish were showed 93% mortality in 12 days. Fish showed clinical sign of infection as lethargic, loss of appetite, pale or darken body color and haemorrhages. Internal organ on death fish showed swollen spleen and kidney and also pale liver. Quantitative PCR analysis on internal organs showed spleen had the highest viral DNA copy number followed by kidney, gill and liver. Histopathological analysis showed hemorrage in these organs and many abnormally hypertrophied cells which is typical histopathological characteristic of megalocytivirus infection. On the second stage of this study was to develop primary cell cultures from its spleen as target organ for propagating megalocytivirus in vitro. We developed primary cell from spleen by enzimatic dissociation. The result showed that primary cell (GPs cell) can grow well at 27 oC and 10% serum in L-15 medium was sufficient for cells growth. GPs cells were infected with giant gourami iridovirus (GGIV) showed enlargement and rounding cells. Virus propagated in GPs cells was highly virulent when injected to giant gourami in artificial infection. Intraperitoneal injection experiments of diluted virus supernatant showed 100% mortality within 7-11 dpi and 97% mortality in 21 days by cohabitation with abnormalities were observed in spleen and kidney. GPs cell was successfully subcultured for more than 30 passages and was found to be susceptible to GGIV as a pathogen of ISKNV infection in cultured-giant gourami. GGIV was propagated in GPs cells for megalocytivirus vaccine development for giant gourami. On the third stage of this study was to develop an effective vaccine and measure its efficacy using relative percent survival (RPS), serological parameters (antibody titers), and molecular (relative expression of gouramy immune genes). The
Keyword: inactivated-vaccine, megalocytivirus, primary cell culture, Osphronemus goramy